St Jude Medical
STJ
STJ was delisted on the 4th of January, 2017.
620 hedge funds and large institutions have $16.6B invested in St Jude Medical in 2015 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 212 increasing their positions, 245 reducing their positions, and 64 closing their positions.
9% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 64
0% more call options, than puts
Call options by funds: $35.8M | Put options by funds: $35.6M
0% more funds holding
Funds holding: 618 → 620 (+2)
2% less capital invested
Capital invested by funds: $16.9B → $16.6B (-$313M)
13% less repeat investments, than reductions
Existing positions increased: 212 | Existing positions reduced: 245
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
Top Buyers
Top Sellers
STJ Hedge Fund Activity: Q4 2015 in Review
620 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in St Jude Medical (STJ) for Q4 2015, worth a combined $16.6B — down 1.8% from $16.9B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new STJ positions and 64 closed out — a net gain of 6 holders — while 212 added to existing stakes and 245 trimmed.
The largest buyer was Massachusetts Financial Services, adding an estimated $115M. The largest seller was Capital Research Global Investors, cutting an estimated $313M.
- 620 institutional investors held St Jude Medical (STJ) as of Q4 2015, up from 618 in Q3 2015.
- Funds reported $16.6B of St Jude Medical stock for Q4 2015, down 1.8% quarter-over-quarter.
- 70 funds opened new St Jude Medical positions in Q4 2015 and 64 closed out, a net change of +6 holders.
- The largest St Jude Medical buyer in Q4 2015 was Massachusetts Financial Services, an estimated $115M added.
- The largest St Jude Medical seller in Q4 2015 was Capital Research Global Investors, an estimated $313M sold.
Based on aggregated 13F filings for Q4 2015.